<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#Cover" roleURI="http://briacell.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#BalanceSheets" roleURI="http://briacell.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#BalanceSheetsParenthetical" roleURI="http://briacell.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#StatementsOfOperationsAndComprehensiveLoss" roleURI="http://briacell.com/role/StatementsOfOperationsAndComprehensiveLoss" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#StatementsOfChangesInShareholdersEquity" roleURI="http://briacell.com/role/StatementsOfChangesInShareholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#StatementOfCashFlows" roleURI="http://briacell.com/role/StatementOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#GeneralAndGoingConcern" roleURI="http://briacell.com/role/GeneralAndGoingConcern" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#SignificantAccountingPolicies" roleURI="http://briacell.com/role/SignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#InvestmentInBcTherapeuticsInc." roleURI="http://briacell.com/role/InvestmentInBcTherapeuticsInc." />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ContingentLiabilitiesAndCommitments" roleURI="http://briacell.com/role/ContingentLiabilitiesAndCommitments" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#FairValueMeasurements" roleURI="http://briacell.com/role/FairValueMeasurements" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ShareholdersEquity" roleURI="http://briacell.com/role/ShareholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#Share-basedCompensation" roleURI="http://briacell.com/role/Share-basedCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#FinancialIncomeNet" roleURI="http://briacell.com/role/FinancialIncomeNet" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ResearchDevelopmentAndClinicalTrialExpensesNet" roleURI="http://briacell.com/role/ResearchDevelopmentAndClinicalTrialExpensesNet" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#SubsequentEvent" roleURI="http://briacell.com/role/SubsequentEvent" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://briacell.com/role/SignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#InvestmentInBcTherapeuticsInc.Tables" roleURI="http://briacell.com/role/InvestmentInBcTherapeuticsInc.Tables" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#FairValueMeasurementsTables" roleURI="http://briacell.com/role/FairValueMeasurementsTables" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ShareholdersEquityTables" roleURI="http://briacell.com/role/ShareholdersEquityTables" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#Share-basedCompensationTables" roleURI="http://briacell.com/role/Share-basedCompensationTables" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#FinancialIncomeNetTables" roleURI="http://briacell.com/role/FinancialIncomeNetTables" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#GeneralAndGoingConcernDetailsNarrative" roleURI="http://briacell.com/role/GeneralAndGoingConcernDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#SignificantAccountingPoliciesDetailsNarrative" roleURI="http://briacell.com/role/SignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfChangesInInvestmentDetails" roleURI="http://briacell.com/role/ScheduleOfChangesInInvestmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfAssetsAndLiabilitiesOfBcTherapeuticsDetails" roleURI="http://briacell.com/role/ScheduleOfAssetsAndLiabilitiesOfBcTherapeuticsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#InvestmentInBcTherapeuticsInc.DetailsNarrative" roleURI="http://briacell.com/role/InvestmentInBcTherapeuticsInc.DetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ContingentLiabilitiesAndCommitmentsDetailsNarrative" roleURI="http://briacell.com/role/ContingentLiabilitiesAndCommitmentsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetails" roleURI="http://briacell.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#FairValueMeasurementsDetailsNarrative" roleURI="http://briacell.com/role/FairValueMeasurementsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#SummaryOfChangesInWarrantsDetails" roleURI="http://briacell.com/role/SummaryOfChangesInWarrantsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfWarrantsOutstandingDetails" roleURI="http://briacell.com/role/ScheduleOfWarrantsOutstandingDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfChangeInFairValueOfWarrantsDetails" roleURI="http://briacell.com/role/ScheduleOfChangeInFairValueOfWarrantsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfValuationOfNonPublicOfferingBrokerWarrantsDetails" roleURI="http://briacell.com/role/ScheduleOfValuationOfNonPublicOfferingBrokerWarrantsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfBriaProWarrantsDetails" roleURI="http://briacell.com/role/ScheduleOfBriaProWarrantsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ShareholdersEquityDetailsNarrative" roleURI="http://briacell.com/role/ShareholdersEquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#SummaryOfNumberOfOptionsGrantedDetails" roleURI="http://briacell.com/role/SummaryOfNumberOfOptionsGrantedDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfNumberOfOptionsGrantedDetailsParenthetical" roleURI="http://briacell.com/role/ScheduleOfNumberOfOptionsGrantedDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfOutstandingAndExercisableOptionsDetails" roleURI="http://briacell.com/role/ScheduleOfOutstandingAndExercisableOptionsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfRestrictedStockUnitsGrantedDetails" roleURI="http://briacell.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfRestrictedStockUnitsGrantedDetailsParenthetical" roleURI="http://briacell.com/role/ScheduleOfRestrictedStockUnitsGrantedDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfBriaproRestrictedStockUnitsGrantedDetails" roleURI="http://briacell.com/role/ScheduleOfBriaproRestrictedStockUnitsGrantedDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfBriaproRestrictedStockUnitsGrantedDetailsParenthetical" roleURI="http://briacell.com/role/ScheduleOfBriaproRestrictedStockUnitsGrantedDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfPerformanceShareUnitsGrantedDetails" roleURI="http://briacell.com/role/ScheduleOfPerformanceShareUnitsGrantedDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfPerformanceShareUnitsGrantedDetailsParenthetical" roleURI="http://briacell.com/role/ScheduleOfPerformanceShareUnitsGrantedDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfShare-basedCompensationExpensesDetails" roleURI="http://briacell.com/role/ScheduleOfShare-basedCompensationExpensesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#Share-basedCompensationDetailsNarrative" roleURI="http://briacell.com/role/Share-basedCompensationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ScheduleOfFinancialIncomeNetDetails" roleURI="http://briacell.com/role/ScheduleOfFinancialIncomeNetDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#ResearchDevelopmentAndClinicalTrialExpensesNetDetailsNarrative" roleURI="http://briacell.com/role/ResearchDevelopmentAndClinicalTrialExpensesNetDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bctx-20260430.xsd#SubsequentEventDetailsNarrative" roleURI="http://briacell.com/role/SubsequentEventDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bctx-20260430.xsd#BCTX_AccountsReceivableAndPrepaidExpensesCurrent" xlink:label="loc_BCTXAccountsReceivableAndPrepaidExpensesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_BCTXAccountsReceivableAndPrepaidExpensesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquitySecuritiesFVNINoncurrent" xlink:label="loc_us-gaapEquitySecuritiesFVNINoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapEquitySecuritiesFVNINoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPrepaidExpenseNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bctx-20260430.xsd#BCTX_SharebasedPaymentReserve" xlink:label="loc_BCTXSharebasedPaymentReserve" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_BCTXSharebasedPaymentReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bctx-20260430.xsd#BCTX_WarrantReserve" xlink:label="loc_BCTXWarrantReserve" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_BCTXWarrantReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Equity (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/StatementOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bctx-20260430.xsd#BCTX_FinancialIncomeExpensesNet" xlink:label="loc_BCTXFinancialIncomeExpensesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_BCTXFinancialIncomeExpensesNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="bctx-20260430.xsd#BCTX_IncreaseDecreaseInAmountsReceivableAndPrepaidExpenses" xlink:label="loc_BCTXIncreaseDecreaseInAmountsReceivableAndPrepaidExpenses" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_BCTXIncreaseDecreaseInAmountsReceivableAndPrepaidExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfShortTermInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/GeneralAndGoingConcern" xlink:title="999012 - Disclosure - GENERAL AND GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/SignificantAccountingPolicies" xlink:title="999013 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/InvestmentInBcTherapeuticsInc." xlink:title="999014 - Disclosure - INVESTMENT IN BC THERAPEUTICS INC." />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ContingentLiabilitiesAndCommitments" xlink:title="999015 - Disclosure - CONTINGENT LIABILITIES AND COMMITMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/FairValueMeasurements" xlink:title="999016 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ShareholdersEquity" xlink:title="999017 - Disclosure - SHAREHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/Share-basedCompensation" xlink:title="999018 - Disclosure - SHARE-BASED COMPENSATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/FinancialIncomeNet" xlink:title="999019 - Disclosure - FINANCIAL INCOME, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ResearchDevelopmentAndClinicalTrialExpensesNet" xlink:title="999020 - Disclosure - RESEARCH, DEVELOPMENT, AND CLINICAL TRIAL EXPENSES, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/SubsequentEvent" xlink:title="999021 - Disclosure - SUBSEQUENT EVENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/SignificantAccountingPoliciesPolicies" xlink:title="999022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/InvestmentInBcTherapeuticsInc.Tables" xlink:title="999023 - Disclosure - INVESTMENT IN BC THERAPEUTICS INC. (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/FairValueMeasurementsTables" xlink:title="999024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ShareholdersEquityTables" xlink:title="999025 - Disclosure - SHAREHOLDERS&#8217; EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/Share-basedCompensationTables" xlink:title="999026 - Disclosure - SHARE-BASED COMPENSATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/FinancialIncomeNetTables" xlink:title="999027 - Disclosure - FINANCIAL INCOME, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/GeneralAndGoingConcernDetailsNarrative" xlink:title="999028 - Disclosure - GENERAL AND GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="999029 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfChangesInInvestmentDetails" xlink:title="999030 - Disclosure - SCHEDULE OF CHANGES IN INVESTMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfAssetsAndLiabilitiesOfBcTherapeuticsDetails" xlink:title="999031 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES OF BC THERAPEUTICS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/InvestmentInBcTherapeuticsInc.DetailsNarrative" xlink:title="999032 - Disclosure - INVESTMENT IN BC THERAPEUTICS INC. (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ContingentLiabilitiesAndCommitmentsDetailsNarrative" xlink:title="999033 - Disclosure - CONTINGENT LIABILITIES AND COMMITMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="999034 - Disclosure - SCHEDULE OF FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="999035 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/SummaryOfChangesInWarrantsDetails" xlink:title="999036 - Disclosure - SUMMARY OF CHANGES IN WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="999037 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfChangeInFairValueOfWarrantsDetails" xlink:title="999038 - Disclosure - SCHEDULE OF CHANGE IN FAIR VALUE OF WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfValuationOfNonPublicOfferingBrokerWarrantsDetails" xlink:title="999039 - Disclosure - SCHEDULE OF VALUATION OF NON PUBLIC OFFERING BROKER WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfBriaProWarrantsDetails" xlink:title="999040 - Disclosure - SCHEDULE OF BRIA PRO WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ShareholdersEquityDetailsNarrative" xlink:title="999041 - Disclosure - SHAREHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/SummaryOfNumberOfOptionsGrantedDetails" xlink:title="999042 - Disclosure - SUMMARY OF NUMBER OF OPTIONS GRANTED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfNumberOfOptionsGrantedDetailsParenthetical" xlink:title="999043 - Disclosure - SCHEDULE OF NUMBER OF OPTIONS GRANTED (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfOutstandingAndExercisableOptionsDetails" xlink:title="999044 - Disclosure - SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfRestrictedStockUnitsGrantedDetails" xlink:title="999045 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNITS GRANTED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfRestrictedStockUnitsGrantedDetailsParenthetical" xlink:title="999046 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNITS GRANTED (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfBriaproRestrictedStockUnitsGrantedDetails" xlink:title="999047 - Disclosure - SCHEDULE OF BRIAPRO RESTRICTED STOCK UNITS GRANTED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfBriaproRestrictedStockUnitsGrantedDetailsParenthetical" xlink:title="999048 - Disclosure - SCHEDULE OF BRIAPRO RESTRICTED STOCK UNITS GRANTED (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfPerformanceShareUnitsGrantedDetails" xlink:title="999049 - Disclosure - SCHEDULE OF PERFORMANCE SHARE UNITS GRANTED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfPerformanceShareUnitsGrantedDetailsParenthetical" xlink:title="999050 - Disclosure - SCHEDULE OF PERFORMANCE SHARE UNITS GRANTED (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfShare-basedCompensationExpensesDetails" xlink:title="999051 - Disclosure - SCHEDULE OF SHARE-BASED COMPENSATION EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensationNoncash" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensationNoncash" />
      <link:loc xlink:type="locator" xlink:href="bctx-20260430.xsd#BCTX_ResearchDevelopmentAndClinicalTrialExpensesIncludingShareBasedCompensation" xlink:label="loc_BCTXResearchDevelopmentAndClinicalTrialExpensesIncludingShareBasedCompensation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEmployeeBenefitsAndShareBasedCompensationNoncash" xlink:to="loc_BCTXResearchDevelopmentAndClinicalTrialExpensesIncludingShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="bctx-20260430.xsd#BCTX_GeneralAndAdministrativeExpensesIncludingShareBasedCompensation" xlink:label="loc_BCTXGeneralAndAdministrativeExpensesIncludingShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEmployeeBenefitsAndShareBasedCompensationNoncash" xlink:to="loc_BCTXGeneralAndAdministrativeExpensesIncludingShareBasedCompensation" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/Share-basedCompensationDetailsNarrative" xlink:title="999052 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ScheduleOfFinancialIncomeNetDetails" xlink:title="999053 - Disclosure - SCHEDULE OF FINANCIAL INCOME, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/ResearchDevelopmentAndClinicalTrialExpensesNetDetailsNarrative" xlink:title="999054 - Disclosure - RESEARCH, DEVELOPMENT, AND CLINICAL TRIAL EXPENSES, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://briacell.com/role/SubsequentEventDetailsNarrative" xlink:title="999055 - Disclosure - SUBSEQUENT EVENT (Details Narrative)" />
</link:linkbase>
